- 'Black Swan' Shuns Public Life Because of Bernanke
- Look Ahead: Markets Count Down to US Jobs Report
- FHA to Toughen Mortgage Rules in Lenders Crackdown
- Obama to Send More Troops; Seeks Afghanistan Exit
- GM Removes CEO Henderson; Whitacre Is Interim Chief
- UK Economy Turned, Inflation to Spike: BoE Economist
- Who Were the Biggest Winners And Losers This Year?
- GE, Comcast Complete Deal Over NBC Universal: Source
- Case Closed but Woods Scrutiny Continues
- Unemployment to Peak at 10.5%: Moody's Economist
- 8 Stocks to Gain on Obama's Afghan Plan: Analysts
- BofA On Proposed Changes In The Housing Bailout Program
- The Future of The Media Landscape
- November Auto Sales Muddle Along
- Busch: What Obama Won't Say Tonight
- Stick with Equities—Avoid Emerging Markets: Laszlo Birinyi
- Pfizer Chomps On A Carrot
- Predictions 2010: Technology
- Spain jobless claims up again
- Ban remains on 65 of 76 Thai industrial projects
- UN suspends approval of Chinese wind farms
- Japan warns drivers to check floor mats in cars
- SKorean foreign currency reserves hit record high
- Not HHS secretary, but in health care fight anyway
- Bacterial disease brucellosis found in Idaho cow
- Union may skip Rockefeller Center tree TV special
- Ford shifts into small cars with Fiesta subcompact
WASHINGTON - Need an MRI scan? Tell the doctor if you use a nicotine patch or any other medication patch — or you'll risk a burn during the MRI.
Patches that ooze medication slowly through the skin are becoming more popular, from over-the-counter nicotine patches to prescription patches that deliver estrogen, pain medication, Alzheimer's or Parkinson's drugs, even an anti-nausea drug for chemotherapy recipients.
But the Food and Drug Administration just discovered that some are missing a key safety warning about MRI compatibility.
More than a quarter of the 60 different drug patches sold contain traces of aluminum or other metals in their backing, the part that makes them stick to the skin, estimated Dr. Sandra Kweder, the FDA's deputy drug director.
You can't see the metal; the patch even may appear completely clear. But affected patches contain just enough metal to conduct electricity, meaning a patch worn during an MRI scan can overheat and cause a skin burn similar to a bad sunburn.
The FDA recently learned of a few patients who suffered patch burns, none severe. In January, tracking the source of one burn, officials found that Teva Pharmaceuticals' fentanyl painkiller patch lacked the MRI warning. The FDA then found a variety of other drug patches also lacked the warning.
On Thursday, the FDA issued a public health advisory: Tell your doctor about any medication patches, so the professional can decide which should be removed before an MRI, how soon before the scan, and when it can be reapplied.
"If there's any uncertainty, just don't wear it in the machine," Kweder said. "It's just the smart thing to do."
As for patch makers, FDA is reviewing every product's label to be sure ones that are supposed to carry the safety warning do. Some may be missing because a patch was reformulated to add metal after its label was written; other times FDA acknowledged it just didn't ensure the warning was present in the first place.
Now the agency is considering having an MRI warning somehow be put on the individual patch, not just the box it comes in.
"We have to look at the different configurations of these patches and what's going to be practical to allow for this," Kweder said.
- Will the Fed raise rates? Will the dollar continue its slide? CNBC experts weigh in on the year ahead.
- What may make this decade stand out are the extremes. After one of the worst global recessions ever, we take a look back.
- Goldman Sachs has forbidden employees from gathering in private holiday parties of 12 or more.
- Do you have what it takes to run your own business? Ask yourself these questions.
- Heavily armed pirates in Somalia have set up a sort of stock exhange to fund their hijackings.
- Since its launch in 1998, Google has become a primary force on the Internet. How much do you know about the company?








